Primary Sjögren's syndrome: Clinical and immunological characteristics of 114 patients;Síndrome de Sjögren primario: Características clínicas e inmunológicas de 114 pacientes

Medicina Clinica

Volumn 116, Issue 19, 2001, Pages 721-725

  Selva O'Callaghan, Albert ^a,b   Bosch Gil, Josep Àngel ^a   Solans Laque, Roser ^a   García, Antonio Segura ^a   Armadans Gil, Lluís ^a   Boeckh Behrens, Tilman Mijares ^a   Tarrés, Miquel Vilardell ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE   (Spain)

Author keywords

Diagnostic criteria; Hepatitis C virus; Lymphoproliferative disorders; Primary sj gren's syndrome

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; SJOEGREN SYNDROME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 0035954158     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(01)71965-3     Document Type: Article

References (35)

1. Talal N. Clinical and pathogenic aspects of Sjögren's syndrome. Semin Clin Immunol 1993; 6: 11-20.
2. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-347.
3. Fox RI. Classification criteria for Sjögren syndrome. Rheum Dis Clir North Am 1994: 20: 391.
4. Anaya JM, McGuff HS, Banks PM, Talal N. Clinicopathological factors relating malignant lymphoina with Sjögren's syndrome. Semin Arthritis Rheum 1996; 25: 337-346
5. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM, and the Members of the European Concerted Action on Sjögren Syndrome. Malignant lymphoma in primary Sjögren's syndrome. A multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999; 42: 1765-1772.
6. Markusse HM, Pillay M, Breedveld FC. The diagnostic value of salivary gland scintigraphy in patients suspected of primary Sjögren syndrome. Br J Rheumatol 1993; 32: 231-235.
7. Klutmann S, Bohuslavizki KH, Kroger S, Bleckmann C, Brenner W, Mester J et al. Quantitative salivary gland scintigraphy. J Nucl Med Technol 1999; 27: 20-26.
8. Wise CM, Woodruff RD. Minor salivaly gland biopsies in patients investigated for primary Sjögren's syndrome. A review of 187 patients. J Rheumatol 1993; 20: 1515-1518.
9. Fox RI, Tornwall J, Michelson P. Current issues in the diagnosis and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1999; 11: 364-371.
10. Tomás S, Coll J, Reth P, Corominas JM. Estudio inmunohistoquímico del infiltrado inflamatorio de la glándula salivai menor en el sindrome de Sjögren y otras enfermedades autoinmunes. Med Clin (Barc) 1998; 111: 681-686.
11. Ramos M, Cervera R, García-Carrasco M, Miret C, Muñoz FJ, Espinosa G et al. Sindrome de Sjögren primario: estudio clinico e inmunológico de 80 pacientes. Med Clin (Barc) 1997; 108: 652-657.
12. Fox RI, Howell FV, Bone RC. Primary Sjögren's syndrome: Clinical and immunopatholical features. Semin Arthritis Rheum 1984; 14: 77.
13. Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semm Arthritis Rheum 2000; 29: 296-304.
14. Alexander EL. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 1993; 19: 869-908.
15. Bachmeyer C, Zuber M, Dupont S, Blanche P, Dhote R, Mas JL. Adie syndrome as the initial sign of primary Sjögren syndrome. Am J Ophtalmol 1997; 123: 591-692.
16. Jiménez-Moreno J, Selva-O'Callaghan A, Rovira-Cañellas A, Solans-Laqué R, Len O, Olias M et al. Trigeminal sensory neuropathy in systemic sclerosis. Br J Rheumatol 1998; 37: 587-589.
17. Moutsopoulos HM, Sarmas JH, Talal N. Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? Rheum Dis North Am 1993; 19: 909-912.
18. Coates T, Slavotinek JP, Rischmueller M, Schultz D, Anderson C, Dellamelva M et al. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. J Rheumatol 1999; 26: 1301-1305.
19. Ioannidis JPA, Moutsopoulos HM. Sjögren's syndrome: too many associations, too limited evidence. The enigmatic example of CNS involvement. Semin Arthritis Rheum 1999; 29: 1-3.
20. García-Carrasco M, Ramos-Casals M, Cervera R, Font J. Síndrome de Sjögren y linfoproliferación. Med Clin (Barc) 2000; 114: 740-746.
21. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberley RP, Budman DR et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 89: 888-892.
22. Hernández JA, Olivé A, Ribera JM, Tena X, Cuxart A, Feliu E. Probability of the development of non-Hodgkin lymphoma in primary Sjögren syndrome. Scand J Rheumatol 1996; 396-397.
23. Mazzaro C, Zagonal V, Monfardini S, Tulissi P, Pussini E, Fanni M et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-550.
24. De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90: 776-782.
25. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-428.
26. Selva-O'Callaghan A, Rodriguez-Pardo D, Sánchez-Sitjes LI, Matas-Pericas L, Solans-Laque R, Bosch-Gil JA et al. Hepatitis C virus infection, Sjögren's syndrome, and non-Hodgkin's lymphoma. Arthritis Rheum 1999; 42: 2489-2490.
27. Drucker Y. Hepatitis C virus infection in patients with Sjögren's syndrome and non-Hodgkin's lymphoma. Arthritis Rheum 2000; 43: 1187.
28. Royer B, Cazals-Hatem D, Sibilia J, Agoalika F, Cayuela J-M, Soussi T et al. Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997; 90:766-775.
29. García-Carrasco M, Ramos M, Cervera R, Font J, Vidal J, Munoz FJ et al. Hepatitis C virus infection in «primary» Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997; 56: 173-175.
30. Anaya JM, Liu DT, D'Souza E, Ogawa N, Luan X, Talal N. Primary Sjögren's syndrome in men. Ann Rheum Dis 1995; 45: 748-751.
31. Haga HJ, Jonsson R. The influence of age on disease manifestations and serological characteristics in primary Sjögren syndrome. Scand J Rheumatol 1999; 28: 227-232.
32. Alexander EL, Arnett FC, Provost TT, Stevens MB. Sjögren's syndrome: association of anti-Ro (SSA) antibodies with vasculitis, hematologic abnormalities and serologic hyperreactivity. Ann Intern Med 1983; 98: 155-159.
33. Simmons-O'Brien E, Chen S, Watson R, Antoni C, Petri M, Hochberg M et al. One Hundred Anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore) 1995: 109-130.
34. Ramos Casals M, García-Carrasco M, Cervera R, Font J. Síndrome de Sjögren e infección por el virus de la hepatitis C. Med Clin (Barc) 1999; 112: 18-719.
35. Ramos-Casals M, García-Carrasco M, Cervera R, Rosas J, Trejo O, De la Red G et al. Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunological description of 35 cases. Medicine (Baltimore) 2001; 80: 1-8.